Despite living in a world mainly dominated by COVID-19, here at CleanAir by Baker, we are still working to support those with careers in patient and clinical care throughout the world.
At CleanAir by Baker, we have been #SupportingScience since 1969 and with new vaccines, therapeutics and treatments worldwide, we will continue to do so now more than ever!
A new blood test discovered by a research team at the Ruhr-University Bochum can predict the risk of Alzheimer’s disease in patients who have previously been clinically diagnosed as not having Alzheimer’s disease, however consider themselves as cognitively impaired.
To discover this, the scientists analyzed blood samples using a newly developed test, from an SCD cohort. Identifying all 22 subjects, who developed Alzheimer’s or dementia within six years.
A recent study led by scientists at Washington University School of Medicine identified checkpoints whereby the immune system is able to monitor the fluid leaving the brain for early signs of infection. This means, that the immune system can tolerate the presence of foreign proteins, antigens or tissues in the brain and spinal cord. This is something that has long puzzled scientists, however the discovery now offers new possibilities for treating those with brain diseases, such as Multiple Sclerosis.
Scientists at the University of Utrecht are currently working to explore the concept of Precision Medicine. As treatments for various illnesses do not have a ‘one size fits all’ way of working, Precision Medicine allows for the patients to be separated into groups based on their genetic make-up and phenotypic determinants. This enables more specific diagnoses and therefore better medical decisions.
Research published by the Journal of Alzheimer’s Disease shows that there are new ways to predict the risk for aMCI, years before clinical diagnosis. The study records direct measures of the brain signatures while an individual is engaged with mental activity are more sensitive and are more accurate predictors of memory decline than current behavioural testing. In addition to this, it has been discovered that left-frontal brainwaves during these memory tasks are good predictors for dementia risk.
A recent collaboration between Sanofi and the Jameel Clinic will look to advance AI and machine learning in order to further develop health solutions in the future. The research teams from both companies will work together to develop and apply AI and machine learning technology to further advance drug discovery, development and treatments in the future.
Make sure you join us in #SupportingScience across all of our social media channels!
Follow us on Facebook, Twitter, LinkedIn and Instagram.
Back to News
Be the first to see our new
brand in January 2023
Be the first to know.